AcquisitionFinTech
Avalo Therapeutics acquired AlmataBio milestone option
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Avalo Therapeutics -> AlmataBio milestone option · $2.25 million plus option for $5.125 million
To modify contingent milestone payments related to prior AlmataBio acquisition.
Open source record (SEC) ↗